Alcohol-associated liver disease
Open accessThe DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.
Abstract
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In ALD, hepatocyte cell death results in the release of DAMPs that, together with gut-derived PAMPs, activate surrounding immune cells and serve as recruiting signals for circulating immune cells [82, 83].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · cited 1×
“Alcohol-associated cirrhosis causes an estimated 25% of global deaths due to liver cirrhosis and up to 40% in certain areas of Europe (146).”
BackgroundMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539 · cited 1×
“Cirrhosis is a necessary intermediate step for A-HCC development and amplifies the overall risk for carcinogenesis in patients with ALD (157, 158).”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“…liver disease, which encompasses all types of fatty liver diseases, now termed MASLD, which replaces the stig-matizing “nonalcoholic fatty liver disease” (NAFLD), and a new category, called MetALD, which includes patients with MASLD who also have significant alcohol consumption (143, 144).”
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 1×
“Indeed, by utilizing scRNA-Seq analysis, two studies have identified new cell subpopulations that drive fibrosis and inflammation in the mouse AH model and human alcohol-as-sociated cirrhosis (120, 121).”
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · cited 1×
“Moreover, alcohol misuse and ALD are associated with small intestinal bacterial overgrowth, alterations of gut microbiota (“dysbiosis”), and bacterial translocation (46, 47).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213 · cited 1×
“In 2010, we introduced binge ethanol intake into the chronically ethanol-fed mice, which causes significant neutrophil infiltration and liver injury (23, 133).”
Self-citation
Cited by
Items 301–361 of 361
Zhang, C., Wang, Z., Kadier, D., Shen, Y., Hao, Z., Zhu, Y., Wu, Q., Li, L., & Jiang, P. (2026) · Journal of Biomedical Research · doi:10.7555/jbr.40.20260064
Moreira, R. D. C., Jalil, E. M., Perazzo, H., Cunha, M., Grinsztejn, E., Moura, I. B., Derrico, M., Monteiro, L., do Nascimento, B. F., Moreira, R. I., et al. (2026) · International Journal of Transgender Health · doi:10.1080/26895269.2026.2656440
Zhang, Y., Wei, T., Wu, J., Lin, C., Zhu, D., Li, Y., Shi, S., Huang, S., Jiang, L., Wang, H., et al. (2026) · Advanced Science · doi:10.1002/advs.202513189 · Cited by 1
Tiantian, X., Jin, Y., Pi, A., Cao, F., Ding, Q., Si, C., Song, Q., & Li, S. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110420
Wang, L., Wang, H. B., Miao, Y., Hasimu, H., Ji, T., Huang, H., Du, G., Aisa, H. A., & Xin, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1823992
“Alcoholic liver disease (ALD), a spectrum of liver injuries induced by long-term excessive alcohol consumption, has emerged as one of the leading causes of liver-related morbidity and mortality worldwide (Wu et al., 2023; Mackowiak et al., 2024).”
Cao, F., Ge, X., Pi, A., Huang, Q., Pei, L., Chen, R., Cao, W., Ding, Q., Yang, M., Song, Q., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10398-3
Tsai, T., Aghayev, M., Ilchenko, S., Sabir, U., McMullen, M. R., Ghaju, S., Chen, X. L., Zhang, G., Chung, W. C. J., Nagy, L. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.728507
Wang, B., Wang, Q., Dong, Y., Li, Y., Liu, J. T., Xiao, Y., Qiu, J. U. N. T. A. O., Dong, J., Xiao, H., & Cui, M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08359-9
Metabolomic machine learning predictor for the diagnosis of alcohol-associated liver disease
Li, Y., Zhao, Y., Wang, Y., Liu, L., Xu, D., Yang, X., Zhao, C., Lin, W., Guo, T., Yue, Z., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121162
Rasic, D., Thiele, M. S., Andersen, P. J., Krag, A. A., & Detlefsen, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11955-z
Ojo, B. A., & Adeniji, C. B. (2026) · Current Hepatology Reports · doi:10.1007/s11901-026-00738-6
Gao, H., Zhang, X., Tian, L., Cheng, Z., Gao, W., Yang, Y., Li, Z., Che, J., Zhu, Y. Z., 谭钰嫔, et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08332-6
Sui, X., Feng, S., Wang, W., Zhang, X., Liu, Y., & Peng, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125474 · Cited by 1
“Recent comprehensive reviews have summarized these intricate mechanisms, consistently highlighting the considerable potential of microbiota-targeted interventions as a novel therapeutic strategy for ALD [15–20].”
Fu, J., Deng, Q., Jiao, J., Chen, Y., Yin, X., & Wang, Z. (2026) · Analytical Methods · doi:10.1039/d6ay00703a
Yimgoua, E. S., Nkondo, E. T., Femoe, U. M., Fassi-Kadji, J. B., Kenfack, M. C., Feussom, N. G., Vázquez, S., Tchuenté, L.-A. T., Sotillo, J., & Jatsa, H. B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13894-3
Opportunities and challenges of dihydrodiol dehydrogenase expression in hepatocellular carcinoma
Kuang, Y., Hu, K., Zhu, H., 林如英, Wang, D., Huang, Y., Yuan, W., chen, J., Sun, Y., & Feng, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105462
Wu, X.-Q., Liu, Y.-Y., Yu, H.-S., Abassa, K.-K., Pan, L.-L., Ke, B.-L., & Guo, Y. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i26.118957
Yang, Z., Lv, Q., Xu, Q., Chen, Y., Yang, Y., Li, Z., Che, H., Wang, G., Wei, W., Wu, J., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.057
“Consequently, there is an urgent need to identify novel therapeutic targets and develop safer, more effective treatment strategies 3 .”
Gut Microbiota and Ageing: A Critical Crosstalk in Alcohol-Related Liver Disease
Tan, Y., Hu, Y., Cao, Z., Wang, X., Yuan, Y., & Chu, H. (2026) · Microorganisms · doi:10.3390/microorganisms14071469
Yimgoua, E. S., Kenfack, C. M., Feussom, N. G., Fassi-Kadji, J. B., Nkondo, E. T., Femoe, U. M., Tchuenté, L.-A. T., & Jatsa, H. B. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013687 · Cited by 1
“…and psychological factors: men’s lower biological sensitivity to the harmful effects of alcohol may influence consumption behaviors [39,45]; social pressure to drink is more pronounced in public and economic spheres; and cultural norms often valorize alcohol as a marker of masculinity…”
Chhetri, P., & Choudhury, A. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100847
Aging, liver, and alcohol-associated liver disease
Liu, T., Zheng, Z., Sun, H., Wang, X., & Gao, Y. (2026) · Hepatobiliary Communications · doi:10.1016/j.hbc.2026.100005
Impact of pharmacist-led fibrosis-4 screening in veterans with high-risk alcohol use
Griebel, C., Eatmon, C. V., Puglisi, G., & Reid, J. M. (2026) · JAPhA Practice Innovations · doi:10.1016/j.japhpi.2026.100127
Zhan, L., Liu, Q., Jiang, X., Hu, Y., Zhou, J., Zhu, S., Wq, L., & Pu, J. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158614
Zuo, F., Wu, Q., Lin, X., Ge, S., Wang, R., Xu, T., & Yan, Q. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158594
Reitz, J., Rosoff, D. B., Pacher, P., & Lohoff, F. W. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100793 · Cited by 1
“Alcohol consumption results in free radical generation and toxin-mediated injury to hepatocytes and mitochondria, driving chronic inflammation, dysregulated lipid metabolism, and progressive steatosis [see Yan et al. (67) and Mackowiak et al. (68) for in-depth discussion].”
The emerging role of neutrophil extracellular traps in liver diseases: a narrative review
Ye, L., Chen, Y., Liu, Z., Ye, J., & Chai, W. (2026) · Medical Molecular Morphology · doi:10.1007/s00795-026-00470-6
Assessment and support of people experiencing problematic substance use at the end of life
Witham, G. (2026) · Nursing Standard · doi:10.7748/ns.2026.e12715
Krutsenko, Y., Matour, B. A., Jiang, L., Liu, J., Walker, L., Taborski, S., Merchant, M. L., Liu, S., Hussey, G. S., Badylak, S. F., et al. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.06.009
Shankarappa, B. M., Mahadevan, J., Murthy, P., Viswanath, B., Devarbhavi, H. C., Jain, S., & Purushottam, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1866012
“This sustained inflammatory response promotes hepatocyte apoptosis, necroinflammation, and contributes to the progression of liver injury (7).”
Jaiswal, S., Malakar, S., Mondal, A., & Jayaprakash, G. (2026) · Tropical Journal of Pharmaceutical and Life Sciences · doi:10.61280/tjpls.v13i4.305
Yu, Y., Zhang, Z., Li, X., Liu, X., Ma, Z., Lv, M., Yu, Z., & Li, Y. (2026) · Small · doi:10.1002/smll.74979
Xu, L., & Wang, H. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.07.031
Ye, L., Wang, Z., Zhu, S., Ding, X., Han, J., Hao, Y., He, C., Jiang, Y., Liu, Z., & Zuo, Z. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70586
Rehabilitation for Alcohol Use Disorder: Interdisciplinary Advances, Challenges, and Opportunities
Meng, G., Su, M., Hu, Z., Hu, J., Cai, Y., & Xiao, J. (2026) · ENGINEERING Health & Rehabilitation Engineering · doi:10.2738/enghre.2026.0008
Sun, J., Wei, R., Wang, X., Gao, M., Cao, S., Meng, X., & Qiao, J. (2026) · Life · doi:10.3390/life16091476
“Alcohol-associated liver disease (ALD) remains one of the leading causes of chronic liver disease worldwide, with severity ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and even hepatocellular carcinoma [79].”
Xu, J., Sang, K., & Zhang, J. (2026) · Metabolites · doi:10.3390/metabo16090666
“CYP2E1 induction further increases ROS generation and lipid peroxidation [21–26].”
Xiang, S., Shi, D., Shi, Y., Xu, Y., Yang, Q., Wang, Z., Feng, M., Xu, J., & Wu, J. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202625401001
Dai, S., Wu, Y., Mao, M., 李守业, Li, Z., Chen, L., Dong, Y., Qiu, P., Dou, X., & Yuan, X. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101791
Li, B., Chen, J., Wei, C., Wei, Y., Pan, C., Liu, T., Wang, Q., Li, S., Zhao, Y., Zhang, M., et al. (2026) · Bioresources and Bioprocessing · doi:10.1186/s40643-026-01112-6
“ALD, a chronic liver disease caused by prolonged and excessive alcohol consumption, exhibits distinct stepwise progression in clinical manifestations (Mackowiak et al. 2024).”
Lin, X., Tong, Y., Luo, Z., Wen, M., Luo, J., Xuan, G., Tan, Y., Xu, S., Li, P., Song, A., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158802
Zhu, H., Wang, X., & Shao, J. (2026) · Biochimie · doi:10.1016/j.biochi.2026.09.004
Chronic liver disease-related osteoporosis: From mechanisms to precision intervention
Wang, W., Liu, G., Yokus, B., Yan, T., Sun, H., Pacher, P., & Wang, Y. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.102029
PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage
Gong, Q., Liu, J., Li, H., Hu, H., Guo, Y., & Pu, C. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118480
Akanbi, A., Bridle, K. R., & Crawford, D. H. (2026) · Bioscience Reports · doi:10.1042/bsr20250106
Cheng, W., Li, N., Zhu, Q., Jiang, C., Pu, S., Lan, W., Zhang, Y., & Du, X. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71510
Zhong, J., Yue, H., Wang, Z., Liu, M., Sun, H., & Song, J. (2026) · Phytotherapy Research · doi:10.1002/ptr.70465
Aniceto, C., Sousa‐Uva, M., Marinho, R. T., & Dias, C. M. (2026) · Acta Médica Portuguesa · doi:10.20344/amp.24411
Mihaila, D. F., Domnariu, H. P., Moga, D. F. C., & Domnariu, C. D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197652
“…dysfunction-associated steatotic liver disease (MASLD), these mechanisms are also relevant to alcohol-related liver disease because both conditions share common pathogenic pathways, including mitochondrial dysfunction, oxidative stress, chronic inflammation, and impaired lipid metabolism [23].”
Lei, J., Zeng, X., Liang, L., Ji, X., Zhao, Y., Huang, C., Yu, D., Sun, Q., Wang, X., Zhu, J.-K., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00528-w
Alotaibi, A., Bhowmik, K. K., Kumar, V., Abou-Gharbia, M. A., Childers, W. E., & Sari, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14102250
Rahangdale, K., Mehtani, R., Nandi, B., Dinda, A. K., Nair, S. V., & Vyas, A. K. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124724
The Natural History of Alcohol-Related Liver Disease: Biopsy and Beyond
Philips, C. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-35658-2_20-1
Kang, X., Tang, Y., Xue, H., Hong, K., Lin, Y., Han, X., Yuan, X., Huang, W., Zhan, J., Guo, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3383-9
Lysosomal exoglycosidases as biomarkers of systemic diseases – what’s new?
Ptaszyńska-Sarosiek, I., Sarosiek, W. W., Sarosiek, G. I., Charuta, A., & Maciejczyk, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1891977
“However, the individual stages of alcoholic liver disease are not clearly differentiated from one another, which makes proper treatment difficult (Mackowiak et al., 2024 serum of patients with alcoholic liver disease confirmed by biopsy or a history of chronic AUD (Faber et al., 1984).”
Zhu, W., Li, K., Zhang, W., Hou, R., Shi, M., Jia, X., Jin, M., & Ge, N. (2026) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2026.078
Li, X., Huai, Q., Zhu, C., Dai, H., Mao, L., Huang, H., Shao, Z., Zhao, W., Wu, X., Li, X., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-339970
Zhang, Y., Su, L., Cheng, H., Wei, W., Xu, W., Bao, X., & Lu, C. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118581
Zhong, J., Liu, M., Feng, X., Liu, G., Sun, H., & Song, J. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2752030
Feng, H., Yuan, X., Xie, Y., Xia, Z., Guo, Z., Liu, X., Li, R., & Wang, W. (2026) · Phytotherapy Research · doi:10.1002/ptr.70498
Integrating multi-omics and systems thinking—The future of liver cancer research
Basera, A., Mpala, S., Fadebi, O. O., Marutha, T., Marima, R., Lolas, G., & Dlamini, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45925-2.00010-x
Metadata
- Authors
- Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gao, Bin
- Venue
- Journal of Clinical Investigation
- Published
- 2024-02-01
- Volume
- 134
- Issue
- 3
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10836812
- OpenAlex
- W4391540982
- Cited by
- 359
- References
- 202
- Citations by year
- 2026: 129 · 2025: 160 · 2024: 70
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- alcoholic liver disease, alcoholic steatohepatitis, alcoholic cirrhosis, pathogenesis, therapeutic target, multi-omics, preclinical models, metabolic dysfunction, disease heterogeneity, translational research
- MeSH terms
- Ethanol, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.